For nearly two decades, the San Antonio Nathan Shock Center has been providing core services to meet the current needs of the geroscience community. Directed by leaders in mammalian and invertebrate aging research, we offer technical services and expertise in several critical areas in the biology of aging.
Dr. Strong received a VA Merit Review Award, title: Detoxification of Biogenic Aldehydes in Parkinson’s Disease – $650,000.read more
Dr. Galvan has been recently elected as President-Elect-Elect of the American Aging Association (AGE)! She will be organizing theread more
Rapamycin and Alzheimer’s disease: Time for a clinical trial? Kaeberlein M, Galvan V Sci Transl Med. 2019 Jan 23;11(476).
Long-term treatment with the mTOR inhibitor rapamycin has minor effect on clinical laboratory markers in middle-aged marmosets. Sills AM,